Pharmaceutical Business review

Cardima signs marketing agreement with On-X Life for ablation system

On-X will market this system to cardiothoracic surgeons nationwide for closed-chest ablation procedures. The system can also be used in open chest, concomitant cases.

Robert Cheney, CEO of Cardima, said: “On-X has developed a prominent presence within the thoracic surgical community and has built tremendous trust with physicians. It is a strong endorsement of the Cardima surgical products that On-X has agreed to introduce our products to their extensive physician customer base.”

Exit mobile version